This inventor holds 1 USPTO granted patent. Top assignee: Nanosystems L.l.c.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Donald R. Snyder
Introduction
Donald R. Snyder is an accomplished inventor based in Limerick, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of non-steroidal anti-inflammatory drugs (NSAIDs). His innovative work has led to advancements that improve the efficacy and safety of these medications.
Latest Patents
One of Donald R. Snyder's notable patents is for "Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer." This patent describes dispersible particles that consist essentially of crystalline NSAID with hydroxypropyl cellulose adsorbed on the surface. The amount of hydroxypropyl cellulose is sufficient to maintain an effective average particle size of less than about 1000 nm. Pharmaceutical compositions containing these particles exhibit unexpectedly reduced gastric irritation following oral administration and/or hastened onset of action. This innovation is crucial for enhancing patient comfort and treatment outcomes.
Career Highlights
Donald R. Snyder has dedicated his career to improving pharmaceutical formulations. His work at Nanosystems L.L.C. has allowed him to focus on developing advanced drug delivery systems. His expertise in the field has made him a respected figure among his peers and in the industry.
Collaborations
Throughout his career, Donald has collaborated with various professionals, including his coworker Nancy M. Franson. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.
Conclusion
Donald R. Snyder's contributions to the pharmaceutical industry through his innovative patents and collaborative efforts have made a significant impact on drug formulation and patient care. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
